Insider Transactions in Q4 2023 at Collegium Pharmaceutical, Inc (COLL)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2023
|
Joseph Ciaffoni President and CEO |
SELL
Open market or private sale
|
Direct |
4,357
-1.56%
|
$130,710
$30.38 P/Share
|
|
Dec 21
2023
|
Joseph Ciaffoni President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,357
+1.54%
|
$91,497
$21.34 P/Share
|
|
Dec 20
2023
|
Joseph Ciaffoni President and CEO |
SELL
Open market or private sale
|
Direct |
26,454
-8.78%
|
$793,620
$30.4 P/Share
|
|
Dec 20
2023
|
Joseph Ciaffoni President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
26,454
+8.07%
|
$555,534
$21.34 P/Share
|
|
Dec 19
2023
|
Joseph Ciaffoni President and CEO |
SELL
Open market or private sale
|
Direct |
14,516
-5.01%
|
$435,480
$30.03 P/Share
|
|
Dec 19
2023
|
Joseph Ciaffoni President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,516
+4.77%
|
$304,836
$21.34 P/Share
|
|
Dec 18
2023
|
Joseph Ciaffoni President and CEO |
SELL
Open market or private sale
|
Direct |
27,798
-9.18%
|
$833,940
$30.04 P/Share
|
|
Dec 18
2023
|
Joseph Ciaffoni President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,798
+8.41%
|
$583,758
$21.34 P/Share
|
|
Nov 27
2023
|
Shirley R. Kuhlmann EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
25,600
-17.64%
|
$640,000
$25.78 P/Share
|
|
Nov 27
2023
|
Shirley R. Kuhlmann EVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
25,600
+15.0%
|
$384,000
$15.9 P/Share
|